Reply to the letters to the editor 'Differential inï¬uence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efï¬cacy in melanoma' by Schilling et al.

Davar, D; Choi, T; Kirkwood, J M

Reply to the letters to the editor 'Differential inï¬uence of vemurafenib and dabrafenib on patients' lymphocytes despite similar clinical efï¬cacy in melanoma' by Schilling et al.

Davar, D; Choi, T; Kirkwood, J M.

Affiliation

Davar D; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
Choi T; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA.
Kirkwood JM; Division of Hematology-Oncology, Department of Medicine, University of Pittsburgh Medical Center, Pittsburgh, USA. Electronic address: kirkwoodjm@upmc.edu.

Ann Oncol ; 26(1): 251-252, 2015 Jan.

Article in En | MEDLINE | ID: mdl-32599685

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2015 Document type: Article Affiliation country:

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google